Skip to main content

Advertisement

Log in

Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

Hematopoietic stem cell transplantation (HCT) is potentially curative for a number of hematologic malignancies, but is associated with high symptom burden. We conducted a randomized sham-controlled trial (RCT) to evaluate efficacy and safety of acupuncture as an integrative treatment for managing common symptoms during HCT.

Methods

Adult patients with multiple myeloma undergoing high-dose melphalan followed by autologous HCT (AHCT) were randomized to receive either true or sham acupuncture once daily for 5 days starting the day after chemotherapy. Patients and clinical evaluators, but not acupuncturists, were blinded to group assignment. Symptom burden, the primary outcome was assessed with the MD Anderson Symptom Inventory (MDASI) at baseline, during transplantation, and at 15 and 30 days post transplantation.

Results

Among 60 participants, true acupuncture produced nonsignificant reductions in overall MDASI core symptom scores and symptom interference scores during transplantation (P = .4 and .3, respectively), at 15 days (P = .10 and .3), and at 30 days posttransplantation (P = .2 and .4) relative to sham. However, true acupuncture was significantly more efficacious in reducing nausea, lack of appetite, and drowsiness at 15 days (P = .042, .025, and .010, respectively). Patients receiving sham acupuncture were more likely to increase pain medication use posttransplantation (odds ratio 5.31, P = .017).

Conclusions

Acupuncture was well tolerated with few attributable adverse events. True acupuncture may prevent escalation of symptoms including nausea, lack of appetite, and drowsiness experienced by patients undergoing AHCT, and reduce the use of pain medications. These findings need to be confirmed in a future definitive study.

Trial registration

NCT01811862

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Copelan EA (2006) Hematopoietic stem-cell transplantation. N Engl J Med 354(17):1813–1826. https://doi.org/10.1056/NEJMra052638

    Article  CAS  PubMed  Google Scholar 

  2. Gertz MA, Dingli D (2014) How we manage autologous stem cell transplantation for patients with multiple myeloma. Blood 124(6):882–890. https://doi.org/10.1182/blood-2014-03-544759

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  3. Giralt S (2011) Stem cell transplantation for multiple myeloma: current and future status. Hematol Am Soc Hematol Educ Program 2011:191–196. https://doi.org/10.1182/asheducation-2011.1.191

    Google Scholar 

  4. Anderson KO, Giralt SA, Mendoza TR, Brown JO, Neumann JL, Mobley GM, Wang XS, Cleeland CS (2007) Symptom burden in patients undergoing autologous stem-cell transplantation. Bone Marrow Transplant 39(12):759–766. https://doi.org/10.1038/sj.bmt.1705664

    Article  CAS  PubMed  Google Scholar 

  5. Campagnaro E, Saliba R, Giralt S, Roden L, Mendoza F, Aleman A, Cleeland C, Weber D, Brown J, Anderson KO (2008) Symptom burden after autologous stem cell transplantation for multiple myeloma. Cancer 112(7):1617–1624. https://doi.org/10.1002/cncr.23299

    Article  PubMed  Google Scholar 

  6. Mosher CE, Redd WH, Rini CM, Burkhalter JE, DuHamel KN (2009) Physical, psychological, and social sequelae following hematopoietic stem cell transplantation: a review of the literature. Psycho Oncology 18(2):113–127. https://doi.org/10.1002/pon.1399

    Article  PubMed  PubMed Central  Google Scholar 

  7. Ramsenthaler C, Osborne TR, Gao W, Siegert RJ, Edmonds PM, Schey SA, Higginson IJ (2016) The impact of disease-related symptoms and palliative care concerns on health-related quality of life in multiple myeloma: a multi-centre study. BMC Cancer 16:427. https://doi.org/10.1186/s12885-016-2410-2

    Article  PubMed  PubMed Central  Google Scholar 

  8. Wang XS, Shi Q, Shah ND, Heijnen CJ, Cohen EN, Reuben JM, Orlowski RZ, Qazilbash MH, Johnson VE, Williams LA, Mendoza TR, Cleeland CS (2014) Inflammatory markers and development of symptom burden in patients with multiple myeloma during autologous stem cell transplantation. Clin Cancer Res 20(5):1366–1374. https://doi.org/10.1158/1078-0432.CCR-13-2442

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Cohen MZ, Rozmus CL, Mendoza TR, Padhye NS, Neumann J, Gning I, Aleman A, Giralt S, Cleeland CS (2012) Symptoms and quality of life in diverse patients undergoing hematopoietic stem cell transplantation. J Pain Symptom Manag 44(2):168–180. https://doi.org/10.1016/j.jpainsymman.2011.08.011

    Article  Google Scholar 

  10. Kaptchuk TJ (2002) Acupuncture: theory, efficacy, and practice. Ann Intern Med 136(5):374–383

    Article  PubMed  Google Scholar 

  11. Huang W, Pach D, Napadow V, Park K, Long X, Neumann J, Maeda Y, Nierhaus T, Liang F, Witt CM (2012) Characterizing acupuncture stimuli using brain imaging with FMRI: a systematic review and meta-analysis of the literature. PLoS One 7(4):e32960. https://doi.org/10.1371/journal.pone.0032960

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  12. Stone JA, Johnstone PA (2010) Mechanisms of action for acupuncture in the oncology setting. Curr Treat Options in Oncol 11(3–4):118–127. https://doi.org/10.1007/s11864-010-0128-y

    Article  Google Scholar 

  13. Han JS (2011) Acupuncture analgesia: areas of consensus and controversy. Pain 152(3 Suppl):S41–S48. https://doi.org/10.1016/j.pain.2010.10.012

    Article  PubMed  Google Scholar 

  14. Pyne D, Shenker NG (2008) Demystifying acupuncture. Rheumatology (Oxford) 47(8):1132–1136. https://doi.org/10.1093/rheumatology/ken161

    Article  CAS  Google Scholar 

  15. Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe J, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G (2006) Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 2:CD002285. https://doi.org/10.1002/14651858.CD002285.pub2

    Google Scholar 

  16. Shen J, Wenger N, Glaspy J, Hays RD, Albert PS, Choi C, Shekelle PG (2000) Electroacupuncture for control of myeloablative chemotherapy-induced emesis: a randomized controlled trial. JAMA 284(21):2755–2761

    Article  CAS  PubMed  Google Scholar 

  17. Rithirangsriroj K, Manchana T, Akkayagorn L (2015) Efficacy of acupuncture in prevention of delayed chemotherapy induced nausea and vomiting in gynecologic cancer patients. Gynecol Oncol 136(1):82–86. https://doi.org/10.1016/j.ygyno.2014.10.025

    Article  PubMed  Google Scholar 

  18. Greenlee H, Balneaves LG, Carlson LE, Cohen M, Deng G, Hershman D, Mumber M, Perlmutter J, Seely D, Sen A, Zick SM, Tripathy D, Society for Integrative O (2014) Clinical practice guidelines on the use of integrative therapies as supportive care in patients treated for breast cancer. J Natl Cancer Inst Monogr 2014(50):346–358. https://doi.org/10.1093/jncimonographs/lgu041

    Article  PubMed  PubMed Central  Google Scholar 

  19. Vickers AJ, Cronin AM, Maschino AC, Lewith G, MacPherson H, Foster NE, Sherman KJ, Witt CM, Linde K, Acupuncture Trialists C (2012) Acupuncture for chronic pain: individual patient data meta-analysis. Arch Intern Med 172(19):1444–1453. https://doi.org/10.1001/archinternmed.2012.3654

    Article  PubMed  PubMed Central  Google Scholar 

  20. Lau CH, Wu X, Chung VC, Liu X, Hui EP, Cramer H, Lauche R, Wong SY, Lau AY, Sit RS, Ziea ET, Ng BF, Wu JC (2016) Acupuncture and related therapies for symptom management in palliative cancer care: systematic review and meta-analysis. Medicine (Baltimore) 95(9):e2901. https://doi.org/10.1097/MD.0000000000002901

    Article  Google Scholar 

  21. Garcia MK, Graham-Getty L, Haddad R, Li Y, McQuade J, Lee RT, Spano M, Cohen L (2015) Systematic review of acupuncture to control hot flashes in cancer patients. Cancer 121(22):3948–3958. https://doi.org/10.1002/cncr.29630

    Article  PubMed  PubMed Central  Google Scholar 

  22. Hackett KL, Deane KH, Strassheim V, Deary V, Rapley T, Newton JL, Ng WF (2015) A systematic review of non-pharmacological interventions for primary Sjogren's syndrome. Rheumatology (Oxford) 54(11):2025–2032. https://doi.org/10.1093/rheumatology/kev227

    Article  Google Scholar 

  23. Mao JJ, Farrar JT, Bruner D, Zee J, Bowman M, Seluzicki C, DeMichele A, Xie SX (2014) Electroacupuncture for fatigue, sleep, and psychological distress in breast cancer patients with aromatase inhibitor-related arthralgia: a randomized trial. Cancer 120(23):3744–3751. https://doi.org/10.1002/cncr.28917

    Article  PubMed  PubMed Central  Google Scholar 

  24. Lao L, Bergman S, Hamilton GR, Langenberg P, Berman B (1999) Evaluation of acupuncture for pain control after oral surgery: a placebo-controlled trial. Arch Otolaryngol Head Neck Surg 125(5):567–572

    Article  CAS  PubMed  Google Scholar 

  25. Lao L, Bergman S, Langenberg P, Wong RH, Berman B (1995) Efficacy of Chinese acupuncture on postoperative oral surgery pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 79(4):423–428

    Article  CAS  PubMed  Google Scholar 

  26. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC (2000) Assessing symptom distress in cancer patients: the M.D. Anderson Symptom Inventory. Cancer 89(7):1634–1646

    Article  CAS  PubMed  Google Scholar 

  27. Jones D, Vichaya EG, Wang XS, Williams LA, Shah ND, Thomas SK, Johnson VE, Champlin RE, Cleeland CS, Mendoza TR (2013) Validation of the M. D. Anderson Symptom Inventory multiple myeloma module. J Hematol Oncol 6:13. https://doi.org/10.1186/1756-8722-6-13

    Article  PubMed  PubMed Central  Google Scholar 

  28. El-Jawahri A, LeBlanc T, VanDusen H, Traeger L, Greer JA, Pirl WF, Jackson VA, Telles J, Rhodes A, Spitzer TR, McAfee S, Chen YA, Lee SS, Temel JS (2016) Effect of inpatient palliative care on quality of life 2 weeks after hematopoietic stem cell transplantation: a randomized clinical trial. JAMA 316(20):2094–2103. https://doi.org/10.1001/jama.2016.16786

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The study was funded by a grant from the Gateway for Cancer Research, and the MSK Integrative Medicine and Translational Research Grant. We also received support from the National Institutes of Health/National Cancer Institute (NIH/NCI) Cancer Center Support Grant P30 CA008748, the AC Israel Foundation, and the Byrne Fund.

Author information

Authors and Affiliations

Authors

Contributions

We would like to thank Yi Chan, Matthew Weitzman, Theresa Affuso (acupuncturists); Khaula Malik, Kelsi Clement, Jeremy Taylor, Mollie McMahon, Janice DeRito (research study assistants); and Andrew Vickers, PhD (biostatistician) for their work in this study, which was supported by funding from the NIH/NCI Cancer Center Support Grant P30 CA008748. In addition, we thank IH and CS for their help in the preparation and submission of this manuscript, which was also supported by funding from NIH/NCI Cancer Center Support Grant P30 CA008748.

Corresponding author

Correspondence to Gary Deng.

Ethics declarations

This study was approved by the Institutional Review Board (IRB) at Memorial Sloan Kettering Cancer Center. All procedures performed were in accordance with the ethical standards of the institutional research committee.

Informed consent

Informed consent was obtained from all individual participants included in the study.

Conflict of interest

Dr. Giralt has received honoraria from Celgene, Takeda, Amgen, Jazz, and Sanofi; served in a consulting/advisory role for Celgene, Takeda, Sanofi, Jazz, Amgen, and Janssen; received research funding from Celgene and Takeda. Dr. Landau has received honoraria from Takeda; served in a consulting/advisory role for Onyx, Spectrum, Takeda, and Prothena; received research funding from Onyx. The remaining authors declare no competing financial interests.

Role of the funder/sponsor

The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Electronic supplementary material

ESM 1

(DOCX 20 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Deng, G., Giralt, S., Chung, D.J. et al. Acupuncture for reduction of symptom burden in multiple myeloma patients undergoing autologous hematopoietic stem cell transplantation: a randomized sham-controlled trial. Support Care Cancer 26, 657–665 (2018). https://doi.org/10.1007/s00520-017-3881-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-017-3881-7

Keywords

Navigation